Trial site
The Beatson West of Scotland Cancer Centre
- 18running trials
- 4closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Prostate cancer6 trials
- Melanoma5 trials
- Head and neck cancer3 trials
- Colorectal cancer2 trials
- Gastric and oesophageal cancer2 trials
- Metastatic breast cancer2 trials
- Multiple myeloma2 trials
- Ovarian cancer2 trials
- Triple-negative breast cancer2 trials
- Bladder cancer1 trial
- Chronic lymphocytic leukaemia1 trial
- and 7 more
- Phase
- Phase 1/27 trials
- Phase 37 trials
- Phase 25 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Active, not recruiting11 trials
- Recruiting6 trials
- Completed2 trials
- Terminated2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Pfizer5 trials
- NuCana plc3 trials
- CellCentric Ltd.1 trial
- Eisai Inc.1 trial
- Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.1 trial
- and 11 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Active, not recruiting
Recruiting
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate Cancer
Recruiting
Active, not recruiting
Active, not recruiting
Study of E7386 in Participants With Selected Advanced Neoplasms
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ovarian cancer2 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Head and neck cancer1 recruiting
- Lung cancer1 recruiting
- Melanoma1 recruiting
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026